← Back to Clinical Trials
Recruiting NCT07275450

NCT07275450 Comparative Study Between Ultrasound Guided Regional Anesthesia for Awake Tympanoplasty Surgery vs General Anesthesia

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07275450
Status Recruiting
Phase
Sponsor Zagazig University
Condition Ultrasound Guided Nerve Block
Study Type INTERVENTIONAL
Enrollment 128 participants
Start Date 2025-12-10
Primary Completion 2026-09-01

Eligibility & Interventions

Sex All sexes
Min Age 21 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Ultrasound-guided regional anesthesia groupControl group

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 128 participants in total. It began in 2025-12-10 with a primary completion date of 2026-09-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this study to evaluate efficacy of ultrasound guided regional anesthesia in performing awake tympanoplasty surgery versus traditional general anesthesia

Eligibility Criteria

Inclusion Criteria: 1. Patients acceptance 2. Age: 21-65 years old 3. Sex: both sex (males or females). 4. Physical status: American Society Anesthesiologist (ASA) І and II. 5. Patients will be scheduled for elective unilateral tympanoplasty. Exclusion Criteria: 1. Contraindication of regional anesthesia: Coagulopathy or use of anticoagulant therapy -local infection at the site of injection- known allergy to local anesthetics (bupivacaine). 2. Neurological disorders affecting sensation in the head and neck. 3. Psychiatric illness, severe anxiety, or inability to cooperate during awake surgery. 4. History of previous neck or parotid surgery affecting nerve anatomy. 5. BMI \> 35 (if it may interfere with ultrasound visualization or landmark identification). 6. Pregnancy. 7. Advanced cardiovascular, respiratory, hepatic and renal diseases

Contact & Investigator

Central Contact

Dina Salem, MD

✉ dinamaghraby@yahoo.com

📞 0109933513

Frequently Asked Questions

Who can join the NCT07275450 clinical trial?

This trial is open to participants of all sexes, aged 21 Years or older, up to 65 Years, studying Ultrasound Guided Nerve Block. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07275450 currently recruiting?

Yes, NCT07275450 is actively recruiting participants. Contact the research team at dinamaghraby@yahoo.com for enrollment information.

Where is the NCT07275450 trial being conducted?

This trial is being conducted at Zagazig, Egypt.

Who is sponsoring the NCT07275450 clinical trial?

NCT07275450 is sponsored by Zagazig University. The trial plans to enroll 128 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology